(E)-Tadehaginoside is the E isomer of Tadehaginoside, a phenylpropanoid glycoside. It plays a role in modulating lipogenesis and glucose consumption, while exhibiting antioxidant properties. By regulating the Nrf2 and NF-κB signaling pathways in hepatocytes, Tadehaginoside contributes to liver protection, preventing oxidative stress damage and inflammation. It is utilized in studies on obesity and diabetes.